`
According to Fortune Business Insights, the global blood group typing market size was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.52 billion in 2026 to USD 5.27 billion by 2034, exhibiting a CAGR of 9.60% during the forecast period. North America dominated the global blood group typing market with a share of 34.70% in 2025.
Blood group typing is a diagnostic test used to determine a person’s blood type. Increasing demand for blood transfusions and organ transplantation procedures is a key factor driving market growth. Rising incidence of trauma and accidents leading to excessive bleeding, along with technological advancements in automated blood typing systems, is further supporting adoption.
BLOOD GROUP TYPING MARKET TRENDS
Adoption of Automated Blood Group Typing Technologies
Automated blood typing technologies such as PCR-based and microarray techniques improve accuracy, speed, and safety of transfusion diagnostics, supporting market expansion.
MARKET DYNAMICS
MARKET DRIVERS
Increase in Number of Blood Donations
Rising voluntary blood donations globally are increasing demand for blood typing and cross-matching procedures.
Rising Transplantation Procedures
Growing organ transplantation procedures are increasing demand for HLA typing tests.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-group-typing-market-101767
MARKET RESTRAINTS
Lack of Infrastructure & Trained Personnel
Limited infrastructure and shortage of skilled professionals in emerging countries restrict market growth.
SEGMENTATION ANALYSIS
By Product
Reagents & kits dominated the market with 80.43% share in 2026 due to high usage in transfusion procedures.
By Test Type
Antibody screening segment held 39.80% share in 2026, driven by prenatal testing and transfusion demand.
By Technique
Serology tests dominated with 59.42% share in 2026 due to ease of use and availability.
By End-user
Independent laboratories & blood banks held 59.42% share in 2026, driven by increasing laboratory networks.
BLOOD GROUP TYPING MARKET REGIONAL OUTLOOK
North America
North America generated USD 0.8 billion in 2025, representing 34.70% share, driven by high transfusion demand.
Europe
Europe accounted for USD 0.65 billion in 2025, supported by increasing blood donation awareness.
Asia Pacific
Asia Pacific recorded USD 0.65 billion in 2025, driven by R&D initiatives and healthcare expansion.
Latin America
Latin America contributed USD 0.11 billion in 2025, supported by improving blood collection systems.
Middle East & Africa
Middle East & Africa reached USD 0.09 billion in 2025, driven by rising transfusion demand.
Get Free Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-group-typing-market-101767
KEY COMPANIES PROFILED
Quotient Limited (Switzerland)
CareDx Inc. (U.S.)
Agena Bioscience, Inc. (U.S.)
DIAGAST (U.S.)
Illumina, Inc. (U.S.)
Grifols, S.A. (Spain)
Immucor, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Merck KGaA (Germany)
QIAGEN (Netherlands)
Beckman Coulter, Inc. (U.S.)
QuidelOrtho Corporation (U.S.)
KEY INDUSTRY DEVELOPMENTS
June 2023: Quotient Limited launched ALBA products in multiple countries.
June 2023: Quotient Limited signed distribution agreement with Transmedic.
May 2023: Bio-Rad Laboratories launched IH-500 NEXT automated system.
April 2023: Metropolis Healthcare launched NextGen HLA typing test.
March 2023: Werfen acquired Immucor, Inc. to expand diagnostics portfolio.
Top comments (0)